Association of the 609 C/T NAD(P)H: quinone oxidoreductase (NQO1) polymorphism with development of cutaneous malignant melanoma

Maryam Naghynajadfard, Nikolas J Hodges, Adam Towler, Amanda J Lee, Joanna Norman, Ryan Doran, Rhiannon M David, Anne E Pheasant, Jerry Marsden, James K Chipman
doi: https://doi.org/10.1101/2022.12.19.22283655

Article usage

Article usage: December 2022 to June 2025

AbstractFullPdf
Dec 2022307831
Jan 2023152124
Feb 2023108417
Mar 202395410
Apr 202385112
May 20235612
Jun 202369412
Jul 20237416
Aug 202390016
Sep 2023104512
Oct 202374810
Nov 20236338
Dec 20237007
Jan 20245846
Feb 20245735
Mar 2024841221
Apr 20244933
May 202461911
Jun 20245038
Jul 202459821
Aug 20244847
Sep 202443310
Oct 20242710
Nov 20243505
Dec 202433111
Jan 20253449
Feb 2025333413
Mar 2025354318
Apr 2025241218
May 2025241018
Jun 2025875
Back to top
Posted December 19, 2022.
Download PDF
Data/Code
Email
Association of the 609 C/T NAD(P)H: quinone oxidoreductase (NQO1) polymorphism with development of cutaneous malignant melanoma
Maryam Naghynajadfard, Nikolas J Hodges, Adam Towler, Amanda J Lee, Joanna Norman, Ryan Doran, Rhiannon M David, Anne E Pheasant, Jerry Marsden, James K Chipman
medRxiv 2022.12.19.22283655; doi: https://doi.org/10.1101/2022.12.19.22283655
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area